CATG (CATG) Stock Price & Analysis
CATG (CATG) fell 3.21% to USD 13.76 as of June 10, 2026 at 13:45 UTC, according to Nexqual real-time market data.
CATG last closed at USD 14.22; the session ranged USD 13.69–13.76 on volume of 3,139 shares. Market capitalization is —, with a 52-week range of USD 12.6–15.35 (BTS). Source: Nexqual, June 10, 2026 at 13:45 UTC.
Key Statistics (as of June 10, 2026 at 13:45 UTC)
| Price | USD 13.76 |
|---|---|
| Change | ▼ 3.21% (down) |
| Previous Close | USD 14.22 |
| Open | USD 14.61 |
| Day Range | USD 13.69 – 13.76 |
| 52-Week Range | USD 12.6 – 15.35 |
| Volume | 3,139 shares |
| Market Cap | — |
| Exchange | BTS |
Technical Analysis (CATG)
Nexqual's technical model rates CATG "SELL" based on 0 bullish and 2 bearish signals across 21 daily candles, as of June 10, 2026 at 13:45 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.72 (neutral) |
Financial Health Score (CATG)
Nexqual rates CATG's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 13:45 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BCII | BCII Enterprises Inc. | USD 0.01 | ▲ 9.09% |
| GCOR | Goldman Sachs Access U.S. Aggre | USD 40.89 | ▲ 0.2% |
| MEDX | Horizon Kinetics Medical ETF | USD 34.46 | ▲ 0.82% |
| ATRX | Adhera Therapeutics Inc. | USD 0 | ▲ 0% |
| PRCS | Parnassus Core Select ETF | USD 27.63 | ▲ 0.73% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:45 UTC. This page is informational and not investment advice.